Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Net Margin (2023 - 2025)

Historic Net Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 9391.8%.

  • Mangoceuticals' Net Margin fell 76723200.0% to 9391.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 4308.37%, marking a year-over-year decrease of 30341700.0%. This contributed to the annual value of 1413.8% for FY2024, which is 1544000.0% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Net Margin is 9391.8%, which was down 76723200.0% from 3221.61% recorded in Q2 2025.
  • Mangoceuticals' Net Margin's 5-year high stood at 733.99% during Q3 2023, with a 5-year trough of 9391.8% in Q3 2025.
  • Moreover, its 3-year median value for Net Margin was 1719.48% (2024), whereas its average is 2647.98%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 14366600bps in 2024, then crashed by -76723200bps in 2025.
  • Quarter analysis of 3 years shows Mangoceuticals' Net Margin stood at 1050.87% in 2023, then tumbled by -76bps to 1851.45% in 2024, then plummeted by -407bps to 9391.8% in 2025.
  • Its last three reported values are 9391.8% in Q3 2025, 3221.61% for Q2 2025, and 4427.47% during Q1 2025.